First Physicians Capital Group Inc
OTC:FPCG
Relative Value
There is not enough data to reliably calculate the relative value of FPCG.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
FPCG Competitors Multiples
First Physicians Capital Group Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
F
|
First Physicians Capital Group Inc
OTC:FPCG
|
10.1m USD | 0.4 | 1.1 | 1.4 | 1.4 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
96.3B USD | 0.2 | 203.4 | 13.6 | 13.6 | |
| US |
|
Cigna Corp
NYSE:CI
|
77.8B USD | 0.3 | 12.5 | 0 | 0 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
65.6B EUR | 0.3 | 12.6 | 8 | 10.2 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
28.1B EUR | 1.3 | 24.5 | 10.7 | 16.3 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.6B EUR | 1.2 | 32.8 | 10.3 | 22.1 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.4B USD | 1.7 | 27.6 | 14.8 | 20.7 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.2B USD | 2.1 | 23.9 | 12.9 | 17.4 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.6B EUR | 0.6 | 16.1 | 6.4 | 13.6 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
13.3B USD | 14.7 | -33.3 | -35.1 | -31.8 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10B USD | 0.8 | 12.9 | 7.4 | 10 |